{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD)-associated genomic deletions and the destabilizing L166P point mutation lead to loss of the cytoprotective DJ-1 protein. The effects of other PD-associated point mutations are less clear.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to DJ-1 protein stability and function, particularly in the context of PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes various assays, including protein stability measurements, co-immunoprecipitation, and cytotoxicity assays, to assess the functional impact of DJ-1 mutations.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they evaluate protein function and cellular consequences relevant to PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes basic controls (wild-type DJ-1) and replicates for the experiments, as indicated by the description of multiple independent experiments and the use of various cell lines.",
          "judgment": "Yes",
          "reasoning": "Both basic controls and replicates were used, suggesting that the assays were performed rigorously."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The paper mentions the use of known pathogenic variants as controls, such as L166P, and tests variants that reach P/LP criteria without relying on PS3/BS3 evidence themselves.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used appropriately to validate the functional assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "[M26I]DJ-1 showed significantly reduced cytoprotection in H2O2-treated MEF cells and failed to suppress ASK1 activity and nuclear export of the death domain-associated protein Daxx.",
          "judgment": "Yes",
          "reasoning": "The functional data clearly indicate a loss of function for the M26I variant, which is consistent with a pathogenic effect."
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No direct OddsPath value is given for the M26I variant, but the functional assays provide robust evidence of pathogenicity.",
          "judgment": "N/A",
          "reasoning": "While OddsPath is not directly calculable from the provided data, the functional assays strongly suggest pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The M26I variant of DJ-1 shows significantly reduced cytoprotective activity and fails to suppress ASK1 activity and nuclear export of Daxx, consistent with a pathogenic effect. The functional evidence is very strong, supporting a PS3_very_strong rating."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "106"
        },
        "variant_string_id": "DJ-1 C106A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD)-associated genomic deletions and the destabilizing L166P point mutation lead to loss of the cytoprotective DJ-1 protein. The effects of other PD-associated point mutations are less clear.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to DJ-1 protein stability and function, particularly in the context of PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper describes various assays, including protein stability measurements, co-immunoprecipitation, and cytotoxicity assays, to assess the functional impact of DJ-1 mutations.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they evaluate protein function and cellular consequences relevant to PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes basic controls (wild-type DJ-1) and replicates for the experiments, as indicated by the description of multiple independent experiments and the use of various cell lines.",
          "judgment": "Yes",
          "reasoning": "Both basic controls and replicates were used, suggesting that the assays were performed rigorously."
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The paper mentions the use of known pathogenic variants as controls, such as L166P, and tests variants that reach P/LP criteria without relying on PS3/BS3 evidence themselves.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used appropriately to validate the functional assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "[C106A]DJ-1 completely lost cytoprotective activity and failed to bind to ASK1, consistent with a pathogenic effect.",
          "judgment": "Yes",
          "reasoning": "The functional data clearly indicate a loss of function for the C106A variant, which is consistent with a pathogenic effect."
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "No direct OddsPath value is given for the C106A variant, but the functional assays provide robust evidence of pathogenicity.",
          "judgment": "N/A",
          "reasoning": "While OddsPath is not directly calculable from the provided data, the functional assays strongly suggest pathogenicity."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The C106A variant of DJ-1 completely loses cytoprotective activity and fails to bind to ASK1, consistent with a pathogenic effect. The functional evidence is very strong, supporting a PS3_very_strong rating."
    }
  ]
}